文献速递妇科

子宫内膜癌监测依从性降低检查使用及后续费用

Endometrial cancer surveillance adherence reduces utilization and subsequent costs.
PubMed 文献 · Gynecol Oncol · 2017-07-19

该回顾性研究比较了2011年SGO指南发布前后2年内,单家城市学术公立医院92例子宫内膜癌监测患者中无症状且体格检查正常者接受CT、Pap涂片和CA125检查的情况;指南发布后CT、CA125和Pap涂片使用显著下降,监测费用降低,末次随访疾病状态无显著差异。

要点

  • 指南发布后监测CT扫描、CA125和Pap涂片使用均显著下降。
  • 两年监测总费用从14102.46美元降至3054.99美元。
  • 末次随访时疾病状态无显著差异。

核心结论

  • 在单家城市学术公立医院,2011年SGO子宫内膜癌监测指南发布仅2年后,临床依从性使CT扫描、CA125和Pap涂片的使用显著下降。
  • 这种减少似乎不影响患者结局,并导致监测费用明显降低。

研究设计与样本

  • 回顾性研究,纳入2009年6月至2013年6月在单家机构接受子宫内膜癌监测的全部患者,共92例(2011年6月前48例,2011年6月后44例)。
  • 评估SGO指南发布前2年和后2年内无症状且体格检查无异常发现的患者接受监测CT扫描、Pap涂片和/或CA125的情况。

主要发现

  • 监测CT扫描:指南前13例(27%) vs 指南后4例(9%),p=0.03。
  • CA125:指南前14例(29%) vs 指南后5例(11%),p=0.035。
  • Pap涂片:指南前34例(71%) vs 指南后8例(18%),p<0.001。
  • 末次随访时疾病状态无显著差异。
  • 机构监测费用:指南前2年14102.46美元,指南后2年3054.99美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In June 2011, the SGO recommended that physical exam and symptoms be the primary surveillance methods in patients with endometrial cancer. We sought to evaluate adherence to these guidelines by comparing the use of CT scans, paps and serum CA125 ordered for endometrial cancer surveillance before and after publication of these guidelines. METHODS: A retrospective review was performed for all patients undergoing surveillance for endometrial cancer at a single institution between June 2009 and June 2013. We assessed the number of patients without symptoms or abnormal physical exam findings who underwent surveillance CT scans, paps and/or CA125 during the 2years pre- and 2years post-SGO guidelines. RESULTS: 92 patients (n=48 pre-6/2011, n=44 post-6/2011) were identified. Mean patient age was 58years. No significant difference in age, ethnicity, body mass index, or disease grade or stage was noted. There was a significant decline in surveillance CT scans (n=13, 27% vs. n=4, 9%, p=0.03), CA125 (n=14, 29% vs. 5, 11%, p=0.035) and paps (n=34, 71% vs. n=8 vs. 18%, p<0.001). There was no significant difference in disease status at the last follow-up. Institutional cost of surveillance also declined ($14,102.46 2years pre-guidelines, $3,054.99 2years post-guidelines). CONCLUSIONS: In a single urban academic public hospital, after only 2years, clinical adherence to the 2011 SGO endometrial cancer surveillance guidelines resulted in a significant decline in the use of CT scans, CA125 and paps. This reduction does not appear to affect patient outcomes and led to an appreciable decrease in surveillance costs.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Schwartz ZP, Frey MK, Philips S, et al. Endometrial cancer surveillance adherence reduces utilization and subsequent costs. Gynecol Oncol. 2017. PMID: 28734496. doi:10.1016/j.ygyno.2017.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。